Company profile
ReRx Therapeutics
Transforming clinical outcomes of patients with severe metabolic disorder
- Industry
- Biotechnology Research
- Employees
- 4
ReRx Therapeutics company summary
ReRx Therapeutics is a company in the Biotechnology Research industry. On LinkedIn the company has around 4 employees.
What technology does ReRx Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About ReRx Therapeutics
ReRx is developing novel, oral therapeutics to treat patients with severe metabolic diseases including obesity, metabolic syndrome, diabetes, and liver diseases. Our therapeutics target metabolic pathways involved in regulating energy homeostasis and improve treatment outcomes compared to similar pharmacological agents. ReRx is part of the Berkeley SkyDeck Cohort 17 (https://skydeck.berkeley.edu).
Compare companies similar to ReRx Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
ReRx Therapeutics rerxtherapeutics.com | Biotechnology Research | 4 | - | - |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about ReRx Therapeutics
What does ReRx Therapeutics do?
ReRx is developing novel, oral therapeutics to treat patients with severe metabolic diseases including obesity, metabolic syndrome, diabetes, and liver diseases. Our therapeutics target metabolic pathways involved in regulating energy homeostasis and improve treatment outcomes compared to similar pharmacological agents. ReRx is part of the Berkeley SkyDeck Cohort 17 (https://skydeck.berkeley.edu).
How many employees does ReRx Therapeutics have?
ReRx Therapeutics has around 4 employees on LinkedIn.
Build a lead list from companies like ReRx Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.